igf-1 lr3 recommended dosage - COA-Tested, 98.31% Pure Product Type_Moisturisers Dihexa - PRAMAH / Size:25 Case

igf-1 lr3 recommended dosage - COA-Tested, 98.31% Pure Product Type_Moisturisers Dihexa - PRAMAH / Size:25 Case

Dihexa - PRAMAH / THE HAVEN

Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Product Type_Moisturisers

Size:25 Case

H., and Beck K